279 related articles for article (PubMed ID: 31152021)
1. Genetic Polymorphisms Predisposing the Interleukin 6-Induced APOBEC3B-UNG Imbalance Increase HCC Risk via Promoting the Generation of APOBEC-Signature HBV Mutations.
Liu W; Wu J; Yang F; Ma L; Ni C; Hou X; Wang L; Xu A; Song J; Deng Y; Xian L; Li Z; Wang S; Chen X; Yin J; Han X; Li C; Zhao J; Cao G
Clin Cancer Res; 2019 Sep; 25(18):5525-5536. PubMed ID: 31152021
[TBL] [Abstract][Full Text] [Related]
2. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
[TBL] [Abstract][Full Text] [Related]
3. Association of a potential functional pre-miR-218 polymorphism and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.
Han Y; Pu R; Han X; Zhao J; Li W; Yin J; Zhang Y; Shen Q; Xie J; Zhang Q; Jiang S; Li J; Zhang H; Wang H; Cao G
Liver Int; 2014 May; 34(5):728-36. PubMed ID: 24118778
[TBL] [Abstract][Full Text] [Related]
4. The genetic polymorphism down-regulating HLA-DRB1 enhancer activity facilitates HBV persistence, evolution and hepatocarcinogenesis in the Chinese Han population.
Deng Y; Li P; Liu W; Pu R; Yang F; Song J; Yin J; Han X; Li C; Zhao J; Wang H; Cao G
J Viral Hepat; 2020 Nov; 27(11):1150-1161. PubMed ID: 32568442
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms in the Wnt/β-catenin pathway genes as predictors of tumor development and survival in patients with hepatitis B virus-associated hepatocellular carcinoma.
Kim SS; Cho HJ; Lee HY; Park JH; Noh CK; Shin SJ; Lee KM; Yoo BM; Lee KJ; Cho SW; Cheong JY
Clin Biochem; 2016 Jul; 49(10-11):792-801. PubMed ID: 26968103
[TBL] [Abstract][Full Text] [Related]
6. HLA-DP polymorphisms affect the outcomes of chronic hepatitis B virus infections, possibly through interacting with viral mutations.
Zhang Q; Yin J; Zhang Y; Deng Y; Ji X; Du Y; Pu R; Han Y; Zhao J; Han X; Zhang H; Cao G
J Virol; 2013 Nov; 87(22):12176-86. PubMed ID: 24006435
[TBL] [Abstract][Full Text] [Related]
7. Effect of functional nuclear factor-kappaB genetic polymorphisms on hepatitis B virus persistence and their interactions with viral mutations on the risk of hepatocellular carcinoma.
Zhang Q; Ji XW; Hou XM; Lu FM; Du Y; Yin JH; Sun XY; Deng Y; Zhao J; Han X; Yang GS; Zhang HW; Chen XM; Shen HB; Wang HY; Cao GW
Ann Oncol; 2014 Dec; 25(12):2413-2419. PubMed ID: 25223483
[TBL] [Abstract][Full Text] [Related]
8. Associations between the single nucleotide polymorphisms of APOBEC3A, APOBEC3B and APOBEC3H, and chronic hepatitis B progression and hepatocellular carcinoma in a Chinese population.
He X; Xu H; Wang X; Wu J; Niu J; Gao P
Mol Med Rep; 2019 Sep; 20(3):2177-2188. PubMed ID: 31322199
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphism of interleukin-16 influences susceptibility to HBV-related hepatocellular carcinoma in a Chinese population.
Li S; Deng Y; Chen ZP; Huang S; Liao XC; Lin LW; Li H; Peng T; Qin X; Zhao JM
Infect Genet Evol; 2011 Dec; 11(8):2083-8. PubMed ID: 22019522
[TBL] [Abstract][Full Text] [Related]
10. Association of Hepatitis B Virus Covalently Closed Circular DNA and Human APOBEC3B in Hepatitis B Virus-Related Hepatocellular Carcinoma.
Luo X; Huang Y; Chen Y; Tu Z; Hu J; Tavis JE; Huang A; Hu Y
PLoS One; 2016; 11(6):e0157708. PubMed ID: 27310677
[TBL] [Abstract][Full Text] [Related]
11. Association of IL-2 polymorphisms and IL-2 serum levels with susceptibility to HBV-related hepatocellular carcinoma in a Chinese Zhuang population.
Peng Q; Li H; Lao X; Deng Y; Chen Z; Qin X; Li S
Infect Genet Evol; 2014 Oct; 27():375-81. PubMed ID: 25173083
[TBL] [Abstract][Full Text] [Related]
12. Interaction of signal transducer and activator of transcription 3 polymorphisms with hepatitis B virus mutations in hepatocellular carcinoma.
Xie J; Zhang Y; Zhang Q; Han Y; Yin J; Pu R; Shen Q; Lu W; Du Y; Zhao J; Han X; Zhang H; Cao G
Hepatology; 2013 Jun; 57(6):2369-77. PubMed ID: 23386590
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of Notch receptors in postsurgical patients with hepatitis B virus-related hepatocellular carcinoma.
Yu T; Han C; Zhu G; Liao X; Qin W; Yang C; Liu Z; Su H; Liu X; Yu L; Liu Z; Lu S; Chen Z; Liang Y; Huang J; Qin X; Gui Y; Li J; Peng T
Cancer Med; 2017 Jul; 6(7):1587-1600. PubMed ID: 28568708
[TBL] [Abstract][Full Text] [Related]
14. Polymorphic APOBEC3 modulates chronic hepatitis B in Moroccan population.
Ezzikouri S; Kitab B; Rebbani K; Marchio A; Wain-Hobson S; Dejean A; Vartanian JP; Pineau P; Benjelloun S
J Viral Hepat; 2013 Oct; 20(10):678-86. PubMed ID: 24010642
[TBL] [Abstract][Full Text] [Related]
15. Associations between activation-induced cytidine deaminase/apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like cytidine deaminase expression, hepatitis B virus (HBV) replication and HBV-associated liver disease (Review).
He X; Li J; Wu J; Zhang M; Gao P
Mol Med Rep; 2015 Nov; 12(5):6405-14. PubMed ID: 26398702
[TBL] [Abstract][Full Text] [Related]
16. HLA-DR genetic polymorphisms and hepatitis B virus mutations affect the risk of hepatocellular carcinoma in Han Chinese population.
Zhao Y; Chen K; Yang H; Zhang F; Ding L; Liu Y; Zhang L; Zhang Y; Wang H; Deng Y
Virol J; 2023 Nov; 20(1):283. PubMed ID: 38037048
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphism of interleukin-6 influences susceptibility to HBV-related hepatocellular carcinoma in a male Chinese Han population.
Tang S; Yuan Y; He Y; Pan D; Zhang Y; Liu Y; Liu Q; Zhang Z; Liu Z
Hum Immunol; 2014 Apr; 75(4):297-301. PubMed ID: 24530755
[TBL] [Abstract][Full Text] [Related]
18. Single Nucleotide Polymorphisms in STAT3 and STAT4 and Risk of Hepatocellular Carcinoma in Thai Patients with Chronic Hepatitis B.
Chanthra N; Payungporn S; Chuaypen N; Piratanantatavorn K; Pinjaroen N; Poovorawan Y; Tangkijvanich P
Asian Pac J Cancer Prev; 2015; 16(18):8405-10. PubMed ID: 26745093
[TBL] [Abstract][Full Text] [Related]
19. IL17A gene polymorphisms, serum IL-17A and IgE levels, and hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection.
Li N; Zhu Q; Li Z; Han Q; Zhang G; Chen J; Lv Y; Xing F; Chen Y; Zeng X; Liu Z
Mol Carcinog; 2014 Jun; 53(6):447-57. PubMed ID: 23280722
[TBL] [Abstract][Full Text] [Related]
20. TLR3 and TLR4 SNP variants in the liver disease resulting from hepatitis B virus and hepatitis C virus infection.
Sghaier I; Zidi S; Mouelhi L; Ghazoueni E; Brochot E; Almawi WY; Loueslati BY
Br J Biomed Sci; 2019 Jan; 76(1):35-41. PubMed ID: 30421643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
